Compare Natl. Oxygen with Similar Stocks
Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -6.40% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.95
The company has declared Negative results for the last 5 consecutive quarters
Risky - Negative EBITDA
Reducing Promoter Confidence
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Other Chemical products
INR 32 Cr (Micro Cap)
NA (Loss Making)
22
0.00%
-8.71
249.65%
-10.74
Total Returns (Price + Dividend) 
Latest dividend: 1 per share ex-dividend date: Sep-18-2013
Risk Adjusted Returns v/s 
Returns Beta
News

National Oxygen Ltd Falls to 52-Week Low of Rs 58 as Sell-Off Deepens
For the fourth consecutive session, National Oxygen Ltd has closed lower, hitting a fresh 52-week low of Rs 58 on 24 Mar 2026. This marks a -12.69% decline over the past four days, underscoring sustained selling pressure amid a broader market that itself is struggling to find footing.
Read full news article
National Oxygen Ltd Falls to 52-Week Low of Rs 60 Amid Continued Downtrend
National Oxygen Ltd, a micro-cap player in the Other Chemical products sector, has touched a new 52-week low of Rs 60 today, marking a significant decline amid a sustained downward trend over recent sessions.
Read full news article
National Oxygen Ltd is Rated Strong Sell
National Oxygen Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Aug 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 March 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article Announcements 
Board Meeting Outcome for Outcome Of The Board Meeting Held On 20Th March 2026
20-Mar-2026 | Source : BSEThe Board of Directors of the Company at its meeting held today i.e on Friday March 20 2026 have inter alia approved the following: a) Issue of up to 950000 (Nine Lakh Fifty Thousand) Equity Shares having a face value of Rs.10/- (Rupees Ten Only) each at a price not less than the price determined in accordance with the SEBI ICDR Regulations on a Preferential Basis to Saraf Housing Development Private Limited a Company forming part of the Promoter Group of the Company b) Appointment of CA S Dehaleesan (Registered Valuer number: [IBBI/RV/04/2019/11659] as the Registered Valuer for determining the price for Preferential Issue. c) Opening of separate bank account for the purpose of Preferential Issue.
Announcement under Regulation 30 (LODR)-Preferential Issue
20-Mar-2026 | Source : BSEIssue of up to 950000 (Nine Lakh Fifty Thousand) Equity Shares having a face value of Rs.10/- (Rupees Ten Only) each at a price not less than the price determined in accordance with SEBI ICDR Regulations 2018 on a Preferential Basis to Saraf Housing Development Private Limited a Company forming part of the Promoter Group of the Company.
Board Meeting Intimation for Board Meeting To Be Held On Friday 20TH March 2026.
17-Mar-2026 | Source : BSENational Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 inter alia to consider and approve Preferential Issue of Equity Shares.
Corporate Actions 
No Upcoming Board Meetings
National Oxygen Ltd has declared 10% dividend, ex-date: 18 Sep 13
No Splits history available
No Bonus history available
National Oxygen Ltd has announced 3:5 rights issue, ex-date: 26 Jun 12
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Rajesh Kumar Saraf (39.14%)
F L Dadabhoy (5.35%)
28.61%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -20.88% vs -15.96% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -122.02% vs 476.47% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -34.09% vs -7.63% in Sep 2024
Growth in half year ended Sep 2025 is 312.76% vs -105.93% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -40.55% vs -6.63% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 182.09% vs -84.52% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -10.34% vs -3.93% in Mar 2024
YoY Growth in year ended Mar 2025 is -116.72% vs -308.86% in Mar 2024






